Can population breast screening programs be leveraged to reduce the burden of breast cancer?

Código QR

Can population breast screening programs be leveraged to reduce the burden of breast cancer?

Guardado en:

Detalles Bibliográficos
Autor principal:	Nehmat Houssami
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/2f365b5acba44d9ebfd3c8c5eddcacc0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening
por: Nehmat Houssami, et al.
Publicado: (2017)

Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality
por: Eunji Choi, et al.
Publicado: (2021)

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease
por: Francisco Beca, et al.
Publicado: (2021)

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
por: Marion Maetens, et al.
Publicado: (2017)

Management of early breast cancer in older women: from screening to treatment
por: Elomrani F, et al.
Publicado: (2015)

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
por: Vogel VG
Publicado: (2011)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)

Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy
por: Yael Artzy-Randrup, et al.
Publicado: (2021)

Identification of genes involved in breast cancer and breast cancer stem cells
por: Apostolou P, et al.
Publicado: (2015)

Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?
por: Morton R, et al.
Publicado: (2017)

Dormancy in breast cancer
por: Banys M, et al.
Publicado: (2012)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Jennifer Xiao, et al.
Publicado: (2021)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Thomas P. Slavin, et al.
Publicado: (2017)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
por: Allan Lipton
Publicado: (2011)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Sasha E. Stanton, et al.
Publicado: (2021)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Mathilde M. M. Almekinders, et al.
Publicado: (2021)

How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies
por: Xinran Wang, et al.
Publicado: (2021)

An alternative model for (breast) cancer predisposition
por: Erik Teugels, et al.
Publicado: (2017)

Current strategies for the prevention of breast cancer
por: Advani P, et al.
Publicado: (2014)

Optical imaging for breast cancer prescreening
por: Godavarty A, et al.
Publicado: (2015)

Breast carcinomas: variations in sonoelastographic appearance
por: Fleury E, et al.
Publicado: (2014)

Breast reconstruction: current and future options
por: Paul Jr H, et al.
Publicado: (2011)

Risk of primary lung cancer after adjuvant radiotherapy in breast cancer—a large population-based study
por: Anna-Karin Wennstig, et al.
Publicado: (2021)

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
por: Yongxian Zhuang, et al.
Publicado: (2021)

Breast cancer in Brazil: epidemiology and treatment challenges
por: Cecilio AP, et al.
Publicado: (2015)

Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Taxanes in the elderly patient with metastatic breast cancer
por: Yardley DA
Publicado: (2015)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis TA, et al.
Publicado: (2015)

Breast cancers are rare diseases—and must be treated as such
por: John M. S. Bartlett, et al.
Publicado: (2017)

Benefits of multidisciplinary teamwork in the management of breast cancer
por: Taylor C, et al.
Publicado: (2013)

Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013)

Immunotherapy in breast cancer: A clinician's perspective
por: Sibapriya Chaudhuri, et al.
Publicado: (2021)

Targeting &gamma;-secretase in breast cancer
por: Han J, et al.
Publicado: (2012)

Multidrug-resistant breast cancer: current perspectives
por: Martin HL, et al.
Publicado: (2014)

Recent advances in the development of breast cancer vaccines
por: Milani A, et al.
Publicado: (2014)

Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
por: Hsin-Yu Liu, et al.
Publicado: (2021)

Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis
por: Martin C. Chang, et al.
Publicado: (2021)

Serum calcium levels, TRPM7, TRPC1, microcalcifications, and breast cancer using breast imaging reporting and data system scores
por: Mandavilli S, et al.
Publicado: (2012)